A Continuous Intracoronary Versus A Standard Intravenous Infusion of Adenosine for Fractional Flow Reserve Assessment - the HYPEREMIC Trial.
To evaluate the accuracy of a continuous intracoronary (IC) adenosine infusion, administered through a novel HYPEREM ™ IC over-the-wire microcatheter, to measure fractional flow reserve (FFR). The HYPEREMIC trial was a randomised, non-inferiority, crossover study in which patients with intermediate coronary lesions were enrolled for sequential pressure wire studies. FFR was measured using intravenous (IV) (140-180 mcg/kg/min) versus continuous non-weight-adjusted IC (360 mcg/min) adenosine. Patients were randomised and blinded to the order in which they received the adenosine, separated by a washout period. The primary endpoint was the mean hyperaemic FFR. Forty-one patients were enrolled at 3 UK sites between June and November 2016. The mean (standard deviation) FFR was 0.82 (±0.09) after IC versus 0.84 (±0.09) after IV adenosine. The difference of -0.02 (95% confidence interval [CI] -0.03 to -0.01) confirmed non-inferiority (margin &lt;0.05) of IC to IV adenosine. Intracoronary adenosine was associated with a shorter mean time to maximal hyperaemia (difference -44 [95% CI -59 to -29] seconds; p&lt;0.0001). Chest discomfort was reported in 32/41 (78.0%) patients during IV adenosine versus 12/41 (29.3%) patients during IC adenosine. Continuous IC adenosine was a reliable, faster and better-tolerated method of achieving maximal hyperaemia compared to IV adenosine.